Stress perfusion-fibrosis cardiac magnetic resonance detects early heart involvement in young asymptomatic, homozygous familial hyperlipidemia with normal routine non-invasive evaluation

International Journal of Cardiology

Volumn 168, Issue 4, 2013, Pages 4570-4572

  Mavrogeni, Sophie ^a   Bratis, Konstantinos ^a   Papachristou, Panagiota ^b   Giannakopoulou, Ekaterini ^b   Karanasios, Evangelos ^b   Kolovou, Genovefa ^a   Van Wijk, Kees ^c   Hautemann, David ^c   Reiber, Johan H C ^c   Papadopoulos, George ^b  

^a ONASSIS CARDIAC SURGERY CENTER   (Greece)

^b AGHIA SOPHIA CHILDREN S HOSPITAL   (Greece)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Cardiovascular magnetic resonance; Homozygous familial hypercholesterolemia; Myocardial fibrosis; Myocardial perfusion

Indexed keywords

ADENOSINE; GADOLINIUM PENTETATE; HIGH DENSITY LIPOPROTEIN; HIGH DENSITY LIPOPROTEIN RECEPTOR;

AORTA VALVE STENOSIS; ATHEROSCLEROSIS; CARDIOVASCULAR MAGNETIC RESONANCE; CONTRAST ENHANCEMENT; CORONARY ARTERY DISEASE; EARLY DIAGNOSIS; ELECTROCARDIOGRAM; EXERCISE TEST; FAMILIAL HYPERLIPEMIA; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE PERFUSION; HEART PERFUSION; HOMOZYGOSITY; HUMAN; LETTER; NON INVASIVE PROCEDURE; PHENOTYPE; PLASMAPHERESIS; PRIORITY JOURNAL; SEX DIFFERENCE; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TREADMILL EXERCISE;

CARDIOVASCULAR MAGNETIC RESONANCE; HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA; MYOCARDIAL FIBROSIS; MYOCARDIAL PERFUSION;

ADOLESCENT; EXERCISE TEST; FEMALE; FIBROSIS; HEART DISEASES; HOMOZYGOTE; HUMANS; HYPERLIPIDEMIAS; MAGNETIC RESONANCE IMAGING; MALE; MYOCARDIAL PERFUSION IMAGING; SIBLINGS;

EID: 84886261433     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2013.06.074     Document Type: Article

References (18)

1. F. Tato, C. Keller, S. Schewe, W. Pinter, and G. Wolfram Echocardiographic changes in patients with heterozygous and homozygous familial hypercholesterolemia: correlation with clinical findings Bildgebung 58 1991 22 25
2. J.L. Goldstein, H.H. Hobbs, and M.S. Brown Familial hypercholesterolemia C.R. Scriver, A.L. Beaudet, W.S. Sly, The metabolic and molecular bases of inherited disease 1995 McGraw-Hill New York, NY 1981 2030
3. J.H. Buhk, A.K. Finck-Wedel, and R. Buchert Screening for atherosclerotic plaques in the abdominal aorta in high-risk patients with multicontrast- weighted MRI: a prospective study at 3.0 and 1.5 tesla Br J Radiol 84 2011 883 889
4. R.M. Summers, J. Andrasko-Bourgeois, and I.M. Feuerstein Evaluation of the aortic root by MRI: insights from patients with homozygous familial hypercholesterolemia Circulation 98 1998 509 518
5. S. Mavrogeni, K. Bratis, and K. van Wijk Myocardial perfusion-fibrosis pattern in systemic sclerosis assessed by cardiac magnetic resonance Int J Cardiol 159 3 Sep 6 2012 e56 e58
6. S. Mavrogeni, Konstantinos Bratis, and Paraskevi Gavra Stress cardiac magnetic resonance reveals myocardial perfusion impairment in asymptomatic diabetes mellitus type I, missed by the routine non-invasive evaluation Int J Cardiol 167 6 Sep 10 2013 e167 e169
7. T.F. Luscher, F.C. Tanner, and G. Noll Lipids and endothelial function: effects of lipid-lowering and other therapeutic interventions Curr Opin Lipidol 7 1996 234 240
8. J.P. Tomás, J.L. Moya, and R. Campuzano Noninvasive assessment of the effect of atorvastatin on coronary microvasculature and endothelial function in patients with dyslipidemia Rev Esp Cardiol 57 2004 909 915
9. M.J. Koziolek, and G.A. Mueller Impact of LDL-apheresis on inflammation and microcirculation Atheroscler Suppl 10 2009 56 58
10. S.F. Wung, and B.E. Aouizerat Gender and ethnic differences in a case-control study of dyslipidemia: using the apolipoprotein A-V gene as an exemplar in cardiovascular genetics Res Theory Nurs Pract 17 2003 281 299
11. J. Pedro-Botet, E.J. Schaefer, and R.G. Bakker-Arkema Apolipoprotein E genotype affects plasma lipid response to atorvastatin in a gender specific manner Atherosclerosis 158 2001 183 193
12. H. Makino, and M. Harada-Shiba Long-term effect of low-density lipoprotein apheresis in patients with homozygous familial hypercholesterolemia Ther Apher Dial 7 4 2003 397 401
13. D.L. Sprecher, E.J. Schaefer, and K.M. Kent Cardiovascular features of homozygous familial hypercholesterolemia: analysis of 16 patients Am J Cardiol 54 1984 20 30
14. R.D. Santos, M.H. Miname, and L.R. Martinez Non-invasive detection of aortic and coronary atherosclerosis in homozygous familial hypercholesterolemia by 64 slice multi-detector row computed tomography angiography Atherosclerosis 197 2008 910 915
15. Y. Horiguchi, A. Yamamoto, T. Kamiya, Y. Arakaki, K. Yazawa, and T. Fujita Cardiovascular findings in familial hypercholesterolemic children Jpn Circ J 55 2 1991 142 148
16. S. Helske, and C.M. Otto Lipid lowering in aortic stenosis: still some light at the end of the tunnel? Circulation 119 2009 2653 2655
17. S.J. Cowell, D.E. Newby, R.J. Prescott, P. Bloomfield, J. Reid, and D.B. Northridge Boon NA; Scottish Aortic Stenosis and Lipid Lowering Trial, Impact on Regression (SALTIRE) Investigators. A randomized trial of intensive lipid-lowering therapy in calcific aortic stenosis N Engl J Med 352 2005 2389 2397
18. A.B. Rossebø, T.R. Pedersen, and K. Boman SEAS Investigators. Intensive lipid lowering with simvastatin and ezetimibe in aortic stenosis N Engl J Med 359 2008 1343 1356